MolNFT v1 · #20110 · protein
Inhibitor bound human angiotensin converting enzyme-related carboxypeptidase (ACE2)
1R4L · Angiotensin I converting enzyme 2: “Inhibitor bound human angiotensin converting enzyme-related carboxypeptidase (ACE2)”. X-ray diffraction, 4 ligands (XX5, NAG, ZN), 4 pockets (best druggability 0.86). MolNFT v1 #20110 on…
- PDB
- 1R4L
- Type
- protein
- Length
- 655 residues
- Chains
- 5
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Angiotensin I converting enzyme 2; Disordered segment of collectrin homology domain
- UniProt
- Q9BYF1
- Ligands
- XX5, NAG, ZN, CL
- Pockets
- 4 · best druggability 0.86
Structure
x-ray diffraction · 5 distinct chains · 53% helix, 4% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Angiotensin I converting enzyme 2 | protein | 597 | 55% helix, 3% strand | Q9BYF1 |
| B | Disordered segment of collectrin homology domain | protein | 6 | 0% helix, 17% strand | — |
| C | Disordered segment of collectrin homology domain | protein | 20 | 0% helix, 10% strand | — |
| D | Disordered segment of collectrin homology domain | protein | 18 | 78% helix, 0% strand | — |
| E | Disordered segment of collectrin homology domain | protein | 14 | 21% helix, 7% strand | — |
Ligands and binding sites
- XX5 · (S,S)-2-{1-carboxy-2-[3-(3,5-dichloro-benzyl)-3H-imidazol-4-yl]-ethylamino}-4-methyl-pentanoic acid · ligand · chains A
- NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A
- ZN · Zinc ion · metal · chains A
- CL · Chloride ion · ion · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 808 | 0.86 | 0.88 | 87 | ZN, XX5 |
| 2 | 687 | 0.67 | 0.76 | 74 | empty |
| 3 | 64 | 0.49 | 0.85 | 19 | empty |
| 4 | 84 | 0.46 | 0.81 | 21 | empty |
Interfaces
8 interfaces between chains.
- C–E · 254 Ų buried · 3 hydrogen bonds · protein-protein
- B–C · 173 Ų buried · 5 hydrogen bonds · protein-protein
- D–E · 156 Ų buried · 0 hydrogen bonds · protein-protein
- A–C · 138 Ų buried · 1 hydrogen bond · protein-protein
- A–E · 78 Ų buried · 0 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 3 disulfide, 2 glycan (disulfide, N-glycosylation).
Compared structures
- 1R4L · Inhibitor Bound Human Angiotensin Converting Enzyme-Related Carboxypeptidase (ACE2) · the same entry in another collection · chain C against C, TM-score 1.00
- 3SCI · Crystal structure of spike protein receptor-binding domain from a predicted SARS… · a predicted model of the same protein · chain A against B, TM-score 0.97
- 3SCK · Crystal structure of spike protein receptor-binding domain from a predicted SARS… · a predicted model of the same protein · chain A against B, TM-score 0.97
- 3SCJ · Crystal structure of spike protein receptor-binding domain from a predicted SARS… · a predicted model of the same protein · chain A against B, TM-score 0.97
- Q9BYF1 · AlphaFold monomer V2.0 prediction for angiotensin-converting enzyme 2 (Q9BYF1) · a predicted model of the same protein · chain A against A, TM-score 0.95
- 3SCI · Crystal structure of spike protein receptor-binding domain from a predicted SARS… · a predicted model of the same protein · chain A against A, TM-score 0.89
- 3SCJ · Crystal structure of spike protein receptor-binding domain from a predicted SARS… · a predicted model of the same protein · chain A against A, TM-score 0.88
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt Q9BYF1
- Elsewhere: RCSB PDB 1R4L · PDBe 1R4L · UniProt Q9BYF1
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.